Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 14 Feb 2024

RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case report

in Thoracic Oncology

Reza Pishdad
Peter B. Illei
Christopher D. Gocke
Douglas W. Ball

Frontiers in Oncology

doi 10.3389/fonc.2024.1360492

2,506 views
5 citations

Review

Published on 13 Feb 2024

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

in Thoracic Oncology

Namariq Abbaker
Fabrizio Minervini
Angelo Guttadauro
Piergiorgio Solli
Ugo Cioffi
Marco Scarci

Frontiers in Oncology

doi 10.3389/fonc.2024.1347464

6,421 views
19 citations

Case Report

Published on 13 Feb 2024

Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib

in Thoracic Oncology

Nana Huang
Tianhao Qu
Chunxia Zhang
Jia Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1269148

3,329 views
6 citations

Original Research

Published on 13 Feb 2024

A new, potential and safe neoadjuvant therapy strategy in epidermal growth factor receptor mutation-positive resectable non-small-cell lung cancer-targeted therapy: a retrospective study

in Thoracic Oncology

Baoxing Liu
Xingyu Liu
Huifang Xing
Haibo Ma
Zhenyu Lv
Yan Zheng
Wenqun Xing

Frontiers in Oncology

doi 10.3389/fonc.2024.1349172

2,438 views
3 citations

Case Report

Published on 12 Feb 2024

Small cell lung cancer with dermatomyositis: a case report

in Thoracic Oncology

Xiaomin Guan
Shi Qiu
Yinghui Xu
Jianjiao Zu
Chao Sun
Ye Guo
Xu Wang
Kewei Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1325991

3,693 views
1 citation

Original Research

Published on 07 Feb 2024

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

in Thoracic Oncology

Shenduo Li
Rami Manochakian
Ruqin Chen
Jaydeepbhai Patel
Jyothik Varun Inampudi
Koshiya R. Hiren
Yujie Zhao
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1306311

3,165 views
1 citation

Original Research

Published on 07 Feb 2024

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

in Thoracic Oncology

Lauren Julia Brown
Victor Khou
Chris Brown
Marliese Alexander
Dasantha Jayamanne
Joe Wei
Lauren Gray
Wei Yen Chan
Samuel Smith
Susan Harden

Frontiers in Oncology

doi 10.3389/fonc.2024.1305720

4,708 views
6 citations

Case Report

Published on 07 Feb 2024

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

in Thoracic Oncology

Elisa De Carlo
Elisa Bertoli
Monica Schiappacassi
Brigida Stanzione
Alessandro Del Conte
Roberto Doliana
Michele Spina
Alessandra Bearz

Frontiers in Oncology

doi 10.3389/fonc.2024.1307458

2,723 views
3 citations

Original Research

Published on 02 Feb 2024

The global research of artificial intelligence in lung cancer: a 20-year bibliometric analysis

in Thoracic Oncology

Ruikang Zhong
Tangke Gao
Jinghua Li
Zexing Li
Xue Tian
Chi Zhang
Ximing Lin
Yuehui Wang
Lei Gao
Kaiwen Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1346010

6,733 views
11 citations

Systematic Review

Published on 02 Feb 2024

Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials

in Thoracic Oncology

Kangdi Cao
Shuaihang Hu
Dandan Wang
Chenxi Qiao
Zhuo Wang
Jinkun Wang
Wei Hou

Frontiers in Oncology

doi 10.3389/fonc.2024.1307836

3,698 views
2 citations

Original Research

Published on 31 Jan 2024

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

in Thoracic Oncology

Patrizia Ciammella
Salvatore Cozzi
Paolo Borghetti
Marco Galaverni
Valerio Nardone
Maria Paola Ruggieri
Matteo Sepulcri
Vieri Scotti
Alessio Bruni
Francesca Zanelli

Frontiers in Oncology

doi 10.3389/fonc.2024.1325249

3,009 views
4 citations

Original Research

Published on 31 Jan 2024

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

in Thoracic Oncology

Ningning Yan
Huixian Zhang
Sanxing Guo
Ziheng Zhang
Yingchun Xu
Liang Xu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1353491

3,267 views
5 citations

Case Report

Published on 29 Jan 2024

Multiple pulmonary cavernous haemangiomas with concurrent primary pulmonary adenocarcinoma: a case report and literature review

in Thoracic Oncology

Xiao Wang
Tao Ren
Hui You
Wenya Han
Jialong Guo
Meifang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1353592

2,228 views
3 citations

Original Research

Published on 29 Jan 2024

Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1

in Thoracic Oncology

Jinghan Wang
Xiao Tang
Xin Liu
Jing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1243432

2,542 views
2 citations

Original Research

Published on 26 Jan 2024

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study

in Thoracic Oncology

Akihiro Yoshimura
Takayuki Takeda
Nobutaka Kataoka
Keiko Tanimura
Mototaka Fukui
Yusuke Chihara
Shota Takei
Hayato Kawachi
Kentaro Nakanishi
Yuta Yamanaka

Frontiers in Oncology

doi 10.3389/fonc.2024.1303543

2,513 views

Case Report

Published on 26 Jan 2024

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report

in Thoracic Oncology

Ruiqi Niu
Yiruo Zhang
Jingdan Pang
Qing Zhou
Yu Lei
Yingying Du

Frontiers in Oncology

doi 10.3389/fonc.2024.1341233

3,044 views
2 citations

Systematic Review

Published on 23 Jan 2024

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

in Thoracic Oncology

Rodrigo Motta-Guerrero
Alejandro Leon Garrido-Lecca
Virgilio E. Failoc-Rojas
Ana Calle-Villavicencio
Robert Villacorta-Carranza
Yesenia Huerta-Collado
Alicia Torres-Mera
Mario J. Valladares-Garrido
Víctor Rivera-Francia
Carlos Carracedo

Frontiers in Oncology

doi 10.3389/fonc.2023.1335373

4,046 views
3 citations

Original Research

Published on 23 Jan 2024

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

in Thoracic Oncology

Anna Valeria Samarelli
Roberto Tonelli
Giulia Raineri
Giulia Bruzzi
Dario Andrisani
Filippo Gozzi
Alessandro Marchioni
Matteo Costantini
Luca Fabbiani
Filippo Genovese

Frontiers in Oncology

doi 10.3389/fonc.2023.1275346

5,641 views
5 citations

Original Research

Published on 23 Jan 2024

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

in Thoracic Oncology

Myriam Mirza
Aseem Shrivastava
Cecile Matthews
Natasha Leighl
Calvin S. H. Ng
David Planchard
Sanjay Popat
Julia Rotow
Egbert F. Smit
Ross Soo

Frontiers in Oncology

doi 10.3389/fonc.2023.1330468

5,193 views

Original Research

Published on 23 Jan 2024

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

in Thoracic Oncology

Magdalena Knetki-Wróblewska
Rafał Dziadziuszko
Tomasz Jankowski
Paweł Krawczyk
Maciej Bryl
Katarzyna Stencel
Anna Wrona
Artur Bandura
Jolanta Smok-Kalwat
Jolanta Rok-Knapińska

Frontiers in Oncology

doi 10.3389/fonc.2024.1341084

4,972 views
5 citations

Case Report

Published on 23 Jan 2024

Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis

in Thoracic Oncology

Yingshun Yang
Guotian Pei
Mingwei Li
Xiaoxue Ma
Shuai Wang
Xianjun Min
Shushi Meng
Jiayue Qin
Huina Wang
Jun Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1276095

2,060 views

Case Report

Published on 19 Jan 2024

Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy

in Thoracic Oncology

Yaoyao Jing
Xiaoxiao Li
Xiaoyuan Sun
Minghan Ren
Ruoxi Xiao
Jiayu Zhao
Zimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1274034

2,781 views
3 citations

Clinical Trial

Published on 18 Jan 2024

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

in Thoracic Oncology

Ramón A. Ortiz Carrodeguas
Geidy Lorenzo Monteagudo
Pedro P. Guerra Chaviano
Irene Álvarez Montané
Eva E. Salomón Saldívar
Leonardo Lobaina Lambert
Kirenia Camacho Sosa
Raúl Bermúdez Pino
Poncio Blanco Mustelier
Elba Valdés Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1287902

7,319 views
10 citations

Case Report

Published on 18 Jan 2024

Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report

in Thoracic Oncology

Junzhu Xu
Bo He
Yunan Wang
Mengjia Wu
Yanyi Lu
Zixuan Su
Shujun Liu
Fengmin Yin
Jian-Guo Zhou
Wei Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1268260

4,385 views
5 citations

1,913 articles

articles

RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case report

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib

A new, potential and safe neoadjuvant therapy strategy in epidermal growth factor receptor mutation-positive resectable non-small-cell lung cancer-targeted therapy: a retrospective study

Small cell lung cancer with dermatomyositis: a case report

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

The global research of artificial intelligence in lung cancer: a 20-year bibliometric analysis

Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

Multiple pulmonary cavernous haemangiomas with concurrent primary pulmonary adenocarcinoma: a case report and literature review

Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1

Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report

Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis

Proteomic profiling of formalin-fixed paraffine-embedded tissue reveals key proteins related to lung dysfunction in idiopathic pulmonary fibrosis

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis

Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report